Front-line and second-line treatment for mantle cell lymphoma in clinical practice: A multicenter retrospective analysis.
Minna HarmanenMarc SorigueMadiha KhanRoosa PrusilaTuula KlaavuniemiEsa KariEsa JantunenKaisa SunelaAino RajamäkiErika AlanneHanne KuitunenArja JukkolaJuan-Manuel SanchoOuti KuittinenAino RönkäPublished in: European journal of haematology (2024)
Front-line treatment in this cohort of MCL was as expected and with a median PFS of over 3.5 years. Second-line treatment strategies were heterogeneous and the median second-line PFS was little over 1 year.